Vascular endothelial growth factor (VEGF), a signalling protein, and osteopontin, a non-collagenous protein, are increased in MM and both increase angiogenesis and osteoclastogenesis [1, 14, 23]. The gene discussed is VEGFA; the disease is Miyoshi myopathy.